The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)

NCT01246804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Depression
Mild Cognitive Impairment

Interventions

DRUG: raltegravir single dose
DRUG: ginkgo biloba multiple dose

Sponsor

Radboud University Medical Center

Collaborators

[object Object]